About

Message from the CEO


At Xenon, we are united by a common mission: to deliver innovative medicines that improve the lives of patients with neurological and psychiatric conditions. This purpose drives everything we do, from advancing our groundbreaking science to building a strong foundation for long-term success.

We are driven to be at the forefront of neuroscience innovation – a company that improves the health of patients through pioneering drug development. The progress we’ve made, including our clinical data, fuels our optimism for the transformative potential of our pipeline.

At Xenon, we prioritize integrity, collaboration, and the pursuit of excellence in all that we do. These principles drive our approach to science, partnerships, and community engagement, ensuring that our efforts make a meaningful impact.

I am incredibly proud of what we’ve accomplished, and I am confident that our continued focus and determination will allow us to achieve even greater breakthroughs for patients and their families.

- Ian Mortimer
President & CEO

Our Team


At the heart of our innovation lies a leadership team with decades of combined experience in advancing science and delivering life-bettering solutions.

Driven by a passion for discovery and patient-centered care, our experts blend scientific excellence with strategic vision: from chemistry and drug development, through nonclinical and clinical development, business, finance, and commercialization, our team is equipped to deliver next-generation treatments for neurological care.

Ian Mortimer MBA, CPA, CMA

President and Chief Executive Officer

Sherry Aulin CPA, CA

Chief Financial Officer

Andrea DiFabio JD

Chief Legal Officer and Corporate Secretary

James Empfield Ph.D.

Executive Vice President, Drug Discovery

Christopher Kenney MD, FAAN

Chief Medical Officer

Shelley McCloskey B.A., Dip. Ed.

Executive Vice President, Human Resources

Matthew D. Ronsheim Ph.D.

Chief Operating Officer

Robin Sherrington Ph.D.

Executive Vice President, Strategy & Innovation

Chris Von Seggern Ph.D., MPH, MBA

Chief Commercial Officer




Science & Pipeline
View Pipeline
Board of Directors
View Directors
Careers
View Careers